Loading
institutionsInstitution
Institut Paoli-Calmettes
The Institut Paoli-Calmettes is the Unicancer comprehensive cancer centre for Marseille and Provence, founded in 1925; it runs a large allogeneic transplant and leukaemia programme, high-volume pancreatic surgery and an early-phase unit within the Marseille Immunopôle cluster.
Also called: IPCCentre de Lutte Contre le Cancer de MarseilleUniversity Hospitals of MarseilleInstitut Paoli-Calmettes (IPC)
Overview
Founded in 1925, the Institut Paoli-Calmettes is the UNICANCER comprehensive cancer centre for Provence-Alpes-Côte d'Azur. Its research arm is the Centre de Recherche en Cancérologie de Marseille (CRCM, with Inserm, CNRS and Aix-Marseille Université), and it belongs to the Marseille Immunopôle cluster alongside the Centre d'Immunologie de Marseille-Luminy. Clinical strengths include a major allogeneic transplant and leukaemia programme, high-volume pancreatic and hepatobiliary surgery, breast oncology under Anthony Gonçalves, and an early-phase unit. It runs a large tumour biobank and a molecular profiling programme for patients across the region.
Location
Marseille, FR
Type
cancer center · Aix-Marseille Université
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#267 · 24 points (0 Newsweek + 0 NCI + 24 from 12 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-15.
Matched to Institut Paoli-Calmettes, including child institutions. 738 works · 7,479 citations · 64% open access · 15% clinical trials · 1% reviews.
Oncology works per year
1502022
1672023
1452024
1872025
892026
Most works
- Nelson Dusetti51 works
- François Bertucci51 works
- Anthony Gonçalvès48 works
- Jonathan Garnier47 works
- Daniel Olive39 works
- Juan Iovanna39 works
- Roch Houot33 works
- Laurent Greillier31 works
- Didier Blaise30 works
- Gabriel Brisou30 works
Most cited
- Haematology and allogeneic transplant
- Pancreatic surgery
- Breast oncology
- Early-phase trials
- Marseille Immunopôle
Norbert Vey
Directeur Général (Director General) of Institut Paoli-Calmettes
HaematologyLeukaemiaCancer centre management
Haematologist specialising in leukaemia who has directed Institut Paoli-Calmettes, the Marseille comprehensive cancer centre, since May 2022.
Anthony Gonçalves
Head of Medical Oncology, Institut Paoli-Calmettes, Marseille
Breast cancerOvarian cancerTranslational research
Anthony Gonçalves is a medical oncologist leading breast and ovarian cancer research at Institut Paoli-Calmettes.
Similar pages
- PersonStephen J. Forman
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Acute myeloid leukaemia.
- TechnologyGamma-delta T cell therapy
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Acute myeloid leukaemia.
- CompanyAllotera Therapeutics (formerly Wugen)
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Acute myeloid leukaemia.
- TechnologyNK cell therapy and CAR-NK
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Acute myeloid leukaemia.
- TargetCD7
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Acute myeloid leukaemia.
- InstitutionPeking University People's Hospital
Shares Allogeneic (off-the-shelf) cell therapy, CAR-T cell therapy, Acute myeloid leukaemia.
- InstitutionRamathibodi Hospital, Mahidol University
Shares Allogeneic (off-the-shelf) cell therapy, Acute myeloid leukaemia, HR-positive / HER2-negative breast cancer.
- PersonChristophe Le Tourneau
Shares UNICANCER, Comprehensive genomic profiling.